Open Access
Numéro
Ann Toxicol Anal
Volume 23, Numéro 3, 2011
Page(s) 139 - 145
DOI https://doi.org/10.1051/ata/2011123
Publié en ligne 13 octobre 2011
  1. Barry PSI. A comparison of concentrations of lead in human tissues. Br J Ind Med. 1975; 32 : 119–139. [PubMed]
  2. Haæ E, Krechniak J. Lead levels in bone and hair of rats treated with lead acetate. Biol Trace Elem Res. 1996, 52 : 293–301. [CrossRef] [PubMed]
  3. Taylor A. Metabolism and toxicology of lead. Rev Environ Health. 1986; 6 : 1–83. [CrossRef] [PubMed]
  4. Winship KA. Toxicity of lead : a review. Adv Drug React. 1989; 8 : 117–152.
  5. Quaterman I,Morrison IN. The influence of high dietary calcium and phosphate on lead uptake and release. Environ Res. 1978; 17 : 60–67. [CrossRef] [PubMed]
  6. Smith CM,DeLuca HF,Tanaka Y,Mahaffey KR. Effects of lead ingestion on functions of vitamin D and its metabolites. J Nutr. 1981; 118 : 824–828.
  7. Mykkanen HM,Fullmer CS,Wasserman RM. Effect of phosphate on the intestinal absorption of lead (203Pb) in chicks. J Nutr. 1984; 114 : 68–74. [PubMed]
  8. Ragan HE. Effects of iron deficiency on the absorption and distribution of lead and cadmium in rats. J Lab Clin Med. 1977; 90 : 700–706. [PubMed]
  9. Watson WS,Hume R,Moore MR. Oral absorption of lead and iron. Lancet. 1980; 2 : 236–237. [CrossRef] [PubMed]
  10. Garnier R, Poupon J. Biomarqueurs de l’exposition aux métaux. Congrès SFT – Biomarqueurs de Toxicité. Paris : Société Française de Toxicologie, 2004.
  11. Rendall REC,Baily P,Soskolne CL. The effect of particle size on absorption of inhaled lead. Am Ind Hyg Ass J. 1975; 36 : 207–213. [CrossRef]
  12. Kaminsky P,Klein M,Duc M. Physiopathologie de l’intoxication par le plomb inorganique. Rev Med Interne. 1993; 14 : 163–170. [CrossRef] [PubMed]
  13. Lauwerys R,Buchet IP,Roels H,Hubermont G. Placental transfer of lead, mercury, cadmium, and carbon monoxide in women. Comparison of the frequency distribution of the biological indices in maternal and umbilical cord blood. Environ Res. 1978; 15 : 278–289.
  14. Bismuth C, Baud F, Conso F, Dally S, Fréjaville J, Garnier R et al. Toxicologie clinique. Paris : Flammarion Médecine Sciences, 2000.
  15. Rabinowitz M,Wetherhill G,Kopple I. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest. 1978; 58 : 260–270. [CrossRef]
  16. Garnier R. Toxicité du plomb et de ses dérivés. EMC-Toxicol Pathol. 2005; 2 : 67–88. [CrossRef]
  17. Viala A, Botta A. Toxicologie. 2e Édition. Paris : Édition Lavoisier, 2005.
  18. Habig WH,Pabst MJ,Jacoby WB. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974; 249 : 7130–7139.
  19. Jacoby WB. The glutathione S-transferase : A group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol. 1978; 46 : 383–414. [PubMed]
  20. Bellomo G,Mirabelli F,Di Monte D,Richelmi P,Thor H. Orrenius C et al. Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. Biochem Pharmacol. 1987; 36(8) : 1313–1320. [CrossRef] [PubMed]
  21. Di Ilio C, Del Boccio G,Casaccia R,Aceto A,Di G,Fedirici Giacomo F. Selenium level and glutathione-dependent enzyme activities in normal and neoplastic human lung tissues. Carcinogenesis. 1987; 8 : 281–284. [CrossRef] [PubMed]
  22. Schirmer RH, Krauth-Siegel RL, Shulz GE. Glutathione reductase. In : Dolphin D, Poulson R, Avramovic O (coordinators). Glutathione : chemical, biochemical and medical aspects (part A). New York : John Wiley and Sons, 1989 : 553–596.
  23. Zhu BT,Liehr JG. Quercetin increases the severity of estradiol induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol. 1994; 125 : 149–158. [CrossRef] [PubMed]
  24. Krohne EG,Schirmer RH,Untucht-Grau R. Glutathione reductase from human erythrocytes, isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem. 1971; 80 : 65–71. [CrossRef]
  25. Aouacheri W,Saka S,Djafer R,Lefranc G. Effet protecteur du diclofénac contre le stress oxydatif induit par la toxicité du paracétamol chez les rats. Ann Biol Clin. 2009; 67(6) : 619–627.
  26. Weckbercker G,Cory JG. Ribonucleotide reductase activity and growth of glutathione-depended mouse leukaemia L 1210 cells in vitro. Cancer Lett. 1988; 40 : 257–264. [CrossRef] [PubMed]
  27. Esterbauer H,Gebicki J,Puhl H,Jungens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992; 13 : 341–390. [NASA ADS] [CrossRef] [EDP Sciences] [PubMed]
  28. Flohe L,Gunzler WA. Analyse of glutathione peroxidise. Methods Enzymol. 1984; 105 : 114–121. [CrossRef] [PubMed]
  29. Horn HD. Glutathione reductase. In : Bergmayer H (coordinateur). Methods of enzymatic analysis. New York : Academic Press, 1965 : 875–879.
  30. Ramirez-cervante B, Embree JW,Hine CH,Nelson KW,Varner MO,Putnam RD. Health assessment of employers with different body burden of lead. J Med Occup. 1978; 20(8) : 610–617. [CrossRef]
  31. Bergmeyer H. Dietary nitrate in man : friend or foe? Clin Chim Acta. 1980; 105 : 147–152. [CrossRef]
  32. Hammond PB, Lerner SI, Gartside P.S, Hanenson IB,Roda SB,Foulkes EC et al. The relationship of biological indices of lead exposure to the health status of workers in a secondary lead smelter. J Occup Med. 1980; 22(7) : 475–484. [PubMed]
  33. Fowler BA, Du Val G. Effects of lead on the kidney : Roles of high-affinity lead binding proteins. Environ Health Perspect. 1991; 91 : 77–80. [CrossRef] [PubMed]
  34. Thylambal R,Saroja PM. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities. Chem Biol. 2004; 147 : 259–271. [NASA ADS] [CrossRef] [EDP Sciences] [PubMed]
  35. Bonsignore D,Calissano P,Cartasegna C. Un senylice metado per la determinazione della α-amino-levulinicodeidratasi nel sangue : comportamento dell’ertzima nell’intossicazione saturmina. Med Lavoro. 1965; 56 : 199–205.
  36. Berrahal AA,Nehdi A,Hajjaji N,Gharbi N,El-Fazâa S. Antioxidant enzymes activities and bilirubin level in adult rat treated with lead. C R Biol. 2007; 330 : 581–588. [CrossRef] [PubMed]
  37. Saxena G,Flora SJS. Lead-induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats. J Biochem Mol Toxicol. 2004; 18(4) : 221–233. [CrossRef] [PubMed]
  38. Gurer H,Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radical Biol Med. 2000; 29(10) : 927–945. [CrossRef]
  39. Upadhyay AK,Mathur R,Bhadauria M,Nirala SK. Therapeutic influence of zinc and ascorbic acid against lead induced biochemical alterations. Thérapie. 2009; 64(6) : 383–388. [CrossRef] [EDP Sciences]
  40. Mestek O,Deyl Z,Miksik I,Novatna J,Pfeifer I,Herget J. Accumulation of lead in tissues after its administration in drinking water laboratory rats. Physiol Res. 1998; 47 : 197–202. [PubMed]
  41. Zhu BT,Liehr JG. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol. 1994; 125 : 149–158. [CrossRef] [PubMed]
  42. Sies H, Brigelius R, Akarboom TPM. Intrahepatic glutathione status. In : Larsson A (coordinator). Functions of glutathione : biochemical, physiological, toxicological and chemical aspects. New York : Raven Press, 1983 : 51–65.